Early Design Decisions that Shape Medical Device Success with Chris Danek, CEO of Bessel | Ep. 63 - Full Transcript | The Med Device Cyber Podcast
Read the complete, searchable transcript of Episode 15 of The Med Device Cyber Podcast - expert conversations on medical device cybersecurity, FDA premarket and postmarket guidance, SBOM management, threat modeling, and penetration testing.
Prefer the listening experience? Open the episode page for the synopsis, key takeaways, topics, and Apple / YouTube listen links.
Episode summary
This episode of the Med Device Cyber Podcast, hosted by Christian Espinosa and Trevor Slattery of Blue Goat Cyber, features guest Chris Danek, the Founder and CEO of Bessel. The discussion centers on the critical need for medical device startups to integrate cybersecurity into their product development process from the very beginning, rather than treating it as a late-stage compliance checkbox. Chris Danek, whose company specializes in helping medtech startups commercialize their innovations, frames the conversation around the concept of creating products with "breakthrough impact." The hosts and guest argue that achieving this impact in today's environment is impossible without a robust and proactive cybersecurity strategy, as neglecting it can lead to devastating financial and product-related consequences. The core argument made throughout the episode is the reframing of medical device cybersecurity from a simple data protection issue to a fundamental component of patient safety. Christian Espinosa vividly illustrates this by describing worst-case scenarios, such as a hacked surgical robot causing paralysis or a compromised defibrillator delivering fatal shocks. This leads to a discussion of several key misconceptions prevalent in the industry. A major point of contention is the false assumption that software developers are inherently cybersecurity experts. Espinosa provocatively states that, in his experience, only about one in a hundred software developers truly understand cybersecurity, emphasizing that the skillset required to build software is fundamentally different from the adversarial mindset needed to secure it. This mistake often results in cybersecurity being pushed to the end of the development cycle, a practice the speakers deem a potential "product killer." To avoid these pitfalls, the experts advocate for a comprehensive, lifecycle-based approach to security. Trevor Slattery highlights the immense costs of late-stage testing, recounting instances where thousands of vulnerabilities were discovered just months before a planned regulatory submission, causing delays and cost overruns exceeding half a million dollars. The solution, they propose, is to start with threat modeling at the conceptual stage to understand what could go wrong and how an attacker might compromise the device. This informs early architectural decisions, ensures security requirements are baked into the design, and guides the selection of secure hardware and software components. The conversation stresses that this proactive stance is not just about appeasing regulators like the FDA, but about de-risking the entire business venture, streamlining development, and ultimately delivering a safer and more effective device to market for the benefit of patients.
Key takeaways from this episode
- In the context of medical devices, the primary driver for cybersecurity is patient safety, not just data protection. A compromised device can lead to direct physical harm.
- A common and dangerous misconception is that software developers are cybersecurity experts. Building software and securing it are two distinct skill sets that require different mindsets.
- Delaying cybersecurity testing until the end of the development lifecycle is a costly mistake that can uncover thousands of vulnerabilities, forcing expensive redesigns and jeopardizing launch timelines.
- Cybersecurity must be integrated throughout the entire product lifecycle, from initial concept and requirements gathering through to post-market surveillance and device disposal.
- Early design choices, such as the selection of third-party software components or microcontrollers, have significant downstream security implications and should be vetted carefully.
- Startups should conduct threat modeling at the earliest stages of development to understand potential attack vectors and build in appropriate security controls from the ground up.
- Regulatory bodies like the FDA have specific cybersecurity expectations that may differ from traditional IT security. Understanding these requirements is crucial for a successful submission.
- Engaging with cybersecurity experts for even a brief consultation early in the process can save a company hundreds of thousands of dollars in cost overruns and delays.